1Arora K, Levine MS, O'Connor MB (1994) The screw gene encodes a ubiquitously expressed member of the TGF-β family required for specification of dorsal cell fates in the Drosophila embryo. Genes Dev 8:2588-2601.

2Hogan BL (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594.

3Tachi K, Takami M, Zhao B, Mochizuki A, Yamada A, Miyamoto Y (2010) Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts. Cell Tissue Res 342:213-220.

4Tachi K, Takami M, Sato H, Mochizuki A, Zhao B, Miyamoto Y (2011) Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-β1. Tissue Eng Part A 17:597-606.

5Cao X, Chen D (2005) The BMP signaling and in vivo bone formation. Gene 357:1-8.

6Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX (2006) Recombinant human BMP-2, and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects: A randomized, controlled trial. J Bone Joint Surg Am 88:1431-1441.

7Villavicencio AT, Burneikiene S, Nelson EL, Bulsara KR, Favors M, Thramann J (2005) Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J. Neurosurg Spine 3:436-443.

8Yoshikawa H, Yoshioka K, Nakase T, Itoh K (2009). Stimulation of ectopic bone formation in response to BMP-2 by Rho kinase inhibitor: a pilot study. Clin Orthop Relat Res 467:3087-3095.

9Boden SD (2005) The ABCs of BMPs. J. Orthopaedic Nursing 24(1): 49-52; quiz 53-4.

10Malafaya PB, Silva GA, Baran ET (2002) Drug Delivery Therapies II: Strategies for Delivering Bone Regenerating Factors. J Current Opinion in Solid State and Materials Science 6: 297–312.

11Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, et al. (1988) Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A 85:9484-9488.

12Carreon LY, Glassman SD, Djurasovic M, Campbell MJ, Puno RM, et al. (2009) RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility study 34:238-2343.

13Villavicencio AT, Burneikiene S, Nelson EL, Bulsara KR, Favors M, Thramann J (2005) Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine 3:436-43.

14Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, et al. (2006) Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 31:542-547.

15Feeley BT, Krenek L, Liu N, Hsu WK (2006) Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone 38: 154-166.

16Woo EJ (2013) Adverse events after recombinant human BMP2 in nonspinal orthopedic procedures. Clin Orthop Relat Res 471: 1707-1711.

17Carreira AC, Lojudice FH, Halcsik E, Navarro RD (2014) Bone morphogenetic proteins: facts, challenges, and future perspectives. J Dent Res 93:335-345.

18Gugala Z, Olmsted D (2003) Osteoinductive by ex vivo Adenovirus- mediated BMP-2 Delivery is Independent of Cell Type. J Gene Therapy 10: 1289-1295.

19Myers G, Prince RL, Kerr DA, Devine A, Woodman RJ, et al. (2015) Tea and flavonoid intake predict osteoporotic fracture risk in elderly Australian women: a prospective study. Am J Clin Nutr 102:958-965.

20Hashmi MA, Shah HS, Khan A, Farooq U, Iqbal J, et al. (2015) Anticancer and Alkaline Phosphatase Inhibitory Effects of Compounds Isolated from the Leaves of Olea ferruginea Royle. Rec. Nat. Prod 9:164-168.

21Mitra C, Das D, Das AS, Preedy VR (2013) Black tea (Camellia sinensis) and bone loss protection. Academic Press 603-612.

22Shen CL, Yeh JK, Cao JJ, Chyu MC, Wang JS (2011) Green tea and bone health: evidence from laboratory studies. Pharmacol Res 64:155-1561.

23Riaz M, Zia-Ul-Haq M, Saad B (2016) Anthocyanins and Human Health: Biomolecular and therapeutic aspects. Springer Briefs in Food, Health, and Nutrition.

24Nash LA, Sullivan PJ, Peters SJ, Ward WE (2015) Rooibos flavonoids, orientin, and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. Mol. Nutr. Food Res 59:443-453.

25Dhar U, Singh UK, Uddin A (2003) Ethanobotany of Bhuyans and Juangs of Orrisa. Medicinal Plants 7:200.

26Warrier PK, Nambiar VPK, Ramankutty C (2003) Indian Medicinal Plants; A compendium of 500 species. Orient Longman 1:368-372.

27Sharma B, Kumar P (2009) Extraction and pharmacological evaluation of some extracts of Tridax procumbens and Capparis deciduas. International Journal of Applied Research in Natural Products 1:5-12.

28Mamun MA, Islam K, Alam MJ, Khatun A, Alam MM, et al. (2015) Flavonoids Isolated from Tridax procumbens (TPF) Inhibit Osteoclasts Differentiation and Bone Resorption. Biol Res 48:51.

29Mamun MA, Hosen MJ, Islam K, Khatun A, Alam MM, Al Bari MA (2015) Tridax procumbens Flavonoids Promote Osteoblast Differentiation and Bone Formation. Biol Res 48:56.

30Mamun MA, Hosen MJ, Khatun A, Alam MM, Al Bari MA (2017) Tridax procumbens Flavonoids: A Prospective Bioactive Compound Increased Osteoblast Differentiation and Trabecular Bone Formation. Biol Res 8;50:28.

31Gulshan R, Sarwar MT, Mamun MA, Alam MJ, Hossain S, Alam MM (2013) Comparative study of antibacterial activity of vancomycin and chemically treated chitosan prepared from shrimp (Macrobrachium rosenbergii) waste. Int. J, Nutrition and Food Scie 2:307-311.

32Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S (2005) Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 36:399-407.

33Kubota K, Iseki S, Kuroda S, Oida S, Iimura T, Duarte WR, et al. (2002) Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 31:465-471.

34Toyoda H, Terai H, Sasaoka R, Oda K, Takaoka K (2005) Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Bone 37:555-562.

35Miyai K, Yoneda M, Hasegawa U, Toita S, Izu Y, Hemmi H, et al. (2009) ANA deficiency enhances bone morphogenetic protein- induced ectopic bone formation via transcriptional events. J Biol Chem 284:10593-600.